Skip to main content
¿Habla español?
Comuníquese con nuestra mesa de ayuda 24/7/365 al 877-635-9545.
Young businesswoman using a digital tablet while standing in front of windows in office Young businesswoman using a digital tablet while standing in front of windows in office Young businesswoman using a digital tablet while standing in front of windows in office

ProAct
Resources

 

Task Force Issues Final Recommendation on PrEP for HIV Prevention

Task Force Issues Final Recommendation on PrEP for HIV Prevention hero image

The 2023 United States Preventive Services Task Force (USPSTF) recommendation for PrEP specifically cites the three medications currently approved by the FDA for use as PrEP. Therefore, it is the position of The Departments, as outlined in FAQ…

FDA Announced Removal of Tirzepatide from the Drug Shortage List

FDA Announced Removal of Tirzepatide from the Drug Shortage List hero image

Doctors and pharmacists are allowed to compound drugs for individual patients when the compounded drug is not commercially available. Licensed outsourcing facilities (LOF) can compound at a higher volume but can only do so in…

2024 Trend Recap

2024 Trend Recap hero image

Notable industry trends throughout 2024 include the continued growth of the specialty market. Across the industry, specialty medications now account for an estimated 54% of spending which has been driven mainly by…

Amneal Announces FDA Approval of Exenatide Injection

Amneal Announces FDA Approval of Exenatide Injection hero image

Amneal announced FDA approval of exenatide 5mcg/1.2mL and 10mcg/2.4mL prefilled pen injection on November 21, 2024. This generic references Byetta® (exenatide – AstraZeneca), a glucagon-like peptide-1 (GLP-1) receptor agonist indicated…

Medicare Drug Price Negotiation Program Announces Drug Selection for New Price Negotiation

Medicare Drug Price Negotiation Program Announces Drug Selection for New Price Negotiation hero image

The Inflation Reduction Act (IRA) of 2022 created the Medicare Drug Price Negotiation (DPN) Program in an effort to decrease the of cost of medications through Medicare. As a result of this program, the Centers for Medicare & Medicaid Services (CMS), select…

ProAct Logo ProAct Logo ProAct Logo
mobile image tablet image desktop image